Literature DB >> 32445465

The essential function of IL-33 in metabolic regulation.

Wenping Li1, Yiyuan Li1, Jin Jin1,2,3.   

Abstract

Interleukin-33 (IL-33) is produced by various types of cells under physical or pathological conditions. As a multifunctional partner in health and disease, current evidence reveals that IL-33 also participates in several metabolic processes. IL-33 has been proven to contribute to regulating the activity of ST2+ group 2 innate lymphoid cells and regulatory T cells in adipose, which leads to the shift of insulin sensitivity and glucose clearance in glucose metabolism, thermogenesis, and adipocyte beiging in adipose metabolism. In this review, we briefly summarize the biological characteristics of Il-33 and discuss its regulatory function in glucose and adipose metabolism. By clarifying the underlying mechanism of IL-33, we highlight the crosstalk between immune response and metabolic processes mediated by IL-33.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IL-33; adipose; glucose; metabolism

Mesh:

Substances:

Year:  2020        PMID: 32445465     DOI: 10.1093/abbs/gmaa045

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  2 in total

Review 1.  Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases.

Authors:  Ibrahim AlZaim; Safaa H Hammoud; Houssam Al-Koussa; Alaa Ghazi; Ali H Eid; Ahmed F El-Yazbi
Journal:  Front Cardiovasc Med       Date:  2020-11-17

2.  Circulating levels of IL-33 are elevated by obesity and positively correlated with metabolic disorders in Chinese adults.

Authors:  Haoneng Tang; Ning Liu; Xiaojing Feng; Yanyi Yang; Yiyuan Fang; Siqi Zhuang; Yufeng Dai; Meilian Liu; Lingli Tang
Journal:  J Transl Med       Date:  2021-02-04       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.